Strain name | Phenotype | Percent of total losses |
---|---|---|
CLB2-db Δ multicopy SIC1 | Viable | 3.38 |
cln1 Δ cln2 Δ cdh1 Δ | Viable | 3.19 |
CLB2-db Δ clb5 Δ clb6 Δ in galactose | Viable | 3.16 |
cdc15 Δ net1-ts cdh1 Δ | Viable | 2.85 |
GAL-CLB2 cdh1 Δ | Inviable | 2.84 |
cln1 Δ cln2 Δ cdh1 Δ GAL-CLN2 | Viable | 2.74 |
CLB2-db Δ in galactose | Inviable | 2.70 |
APC-A | Viable | 2.40 |
APC-A sic1 Δ | Viable | 2.39 |
CLB5-db Δ pds1 Δ | Viable | 2.35 |
APC-A cdh1 Δ multicopy SIC1 | Viable | 2.31 |
cdh1 Δ | Viable | 2.24 |
cln1 Δ cln2 Δ cln3 Δ sic Δ | Viable | 2.03 |
bck2 Δ | Viable | 1.93 |
GALL-CDC20 sic1 Δ cdh1 Δ | Viable | 1.84 |
APC-A cdh1 Δ in galactose | Inviable | 1.72 |
clb5 Δ clb6 Δ cdc20 Δ pds1 Δ | Viable | 1.69 |
cln3 Δ bck2 Δ sic Δ | Inviable | 1.67 |
cln1 Δ cln2 Δ | Viable | 1.54 |
APC-A sic1 Δ cdc6 Δ2-49 | Viable | 1.53 |